“…These data suggest that the prevalence of recombinant forms of SARS-CoV-2 may be consequently low ( Nie et al, 2020 ; Wang et al, 2020 ; VanInsberghe et al, 2021 ). On the other hand, current tracking of SARS-CoV-2 mutations has provided evidence of the contribution of both inter- and intra-variant recombination of SARS-CoV-2 genomes developing emerged recombinants such as XD (Delta AY.4/Omicron BA.1) XE (Omicron BA.1/BA.2), XF (Delta/Omicron BA.1), XL (Omicron BA.1/BA.2), XG (Omicron BA.1/BA.2), XN (Omicron BA.1/BA.2), XQ (Omicron BA.1/BA.2), XR (Omicron BA.1/BA.2), and XAG (Omicron BA.1/BA.2) ( Wang et al, 2022 ; Chakraborty et al, 2022 ; Silva et al, 2022 ). If we observe the target N501Y substitution of SARS-CoV-2 isolated from the patients described in our study and the possibility of co-infection with the 501N variant, both forms of the virus genome would be differentiated already with VirSNiP N501Y/melting curve analysis.…”